Transgene Biotek Limited (526139) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Transgene Biotek Limited (526139) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Transgene Biotek Limited (526139) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Transgene Biotek Limited (526139) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
22 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Transgene Biotek Limited (Transgene) is a biotechnology company that develops and commercializes biogeneric drugs and biotech products. The companys activities include research and development of vaccines. Transgenes products include TrabiDHA, a dietary supplement; Tacrolimus, an immunosuppressant drug to prevent the rejection of transplanted organs; and Orlistat, an anti-obesity drug. The company's facilities include bioreactor/fermenter capacities, downstream facilities and supporting infrastructure. The company serves various therapatic areas such as oncolgy, auto immune, drug delivery and biogenerics.

Transgene Biotek Limited (526139) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent

  
Source:
Document ID
GDPH82537D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Transgene Biotek Limited, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Transgene Biotek Limited, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Transgene Biotek Limited, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Transgene Biotek Limited, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Transgene Biotek Limited, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
Transgene Biotek Limited, Pharmaceuticals &Healthcare, Deal Details109
  Partnerships101
    Transgene Biotek Enters Into Co-Development Agreement With Armour Therapeutics For AT-001102
  Licensing Agreements121
    Transgene Biotek Enters Into Licensing Agreement With Atral Cipan For Tacrolimus121
    Transgene Biotek Enters Into Licensing Agreement With Dr Reddy's Labs131
  Equity Offering141
    Transgene Biotek Completes Offering Of Global Depository Receipts For US$17.5 Million141
    Transgene Biotek Completes Offering Of Global Depository Receipts For US$23 Million151
  Asset Transactions161
    Transgene Biotek Sells Technology For Erythropoietin To TSS Export For US$5 Million161
  Acquisition171
    Transgene Biotek Plans To Sell Stake In The Company171
    Transgene Biotek Terminates Acquisition Of Marillion Pharma181
Transgene Biotek Limited - Key Competitors191
Key Employees201
Locations And Subsidiaries211
  Head Office211
Appendix221
  Methodology221
  About GlobalData221
  Contact Us221
  Disclaimer221

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Transgene Biotek Limited (526139) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Transgene-Biotek-Limited-526139-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7705>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Transgene Biotek Limited (526139) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Transgene-Biotek-Limited-526139-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7705>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research